https://www.selleckchem.com/pr....oducts/enfortumab-ve
AXOS supplementation was bifidogenic and resulted in changes in human gut microbiota composition that depended on the initial microbiota profile, specifically the presence or absence of Prevotella spp. as a major component of the microbiota. Our data therefore suggest that initial profiling of individuals through gut microbiota analysis should be considered important when contemplating nutritional interventions that rely on prebiotics. Clinical trial registration number NCT02693782 . Registered 29 February 2016 - Retrosp
Like
Comment
Share
